Welcome to our dedicated page for Bankwell Financi SEC filings (Ticker: BWFG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Bankwell Financial Group, Inc. (NASDAQ: BWFG), the bank holding company for Bankwell Bank. Through these documents, investors can review how the company reports its commercial banking activities, financial condition, and capital position.
Bankwell’s periodic and current reports describe results of operations and financial condition, including net interest income, noninterest income, pre-tax, pre-provision net revenue (PPNR), net interest margin, and key profitability ratios such as return on average assets and return on average shareholders’ equity. Filings also present details on noninterest expense, efficiency ratio calculations, and explanations of non-GAAP financial measures.
The company discloses asset quality and credit metrics, including nonaccrual loans by portfolio segment, other real estate owned, nonperforming loans and nonperforming assets as a percentage of total loans and total assets, and the allowance for credit losses on loans. Tables in the filings show charge-offs, recoveries, and provision for credit losses over time, along with the relationship between the allowance and nonperforming loans.
Capital information is another focus of Bankwell’s regulatory reporting. Filings include total capital to risk-weighted assets, common equity tier 1 capital to risk-weighted assets, tier 1 capital to average assets, and tangible common equity to tangible assets. Dividend activity is also documented, with current reports on Form 8-K describing quarterly dividend declarations and related dates.
On Stock Titan, these SEC filings are updated from EDGAR and paired with AI-powered summaries that highlight important items, explain technical terms, and help readers interpret complex tables and ratios. Users can quickly identify key trends in earnings, credit quality, capital, and dividends without reading every line of the underlying documents, while still having direct access to the full filings for deeper analysis.
Bankwell Financial Group director Eric J. Dale received a grant of 1,455 shares of restricted common stock on February 9, 2026. The award was issued at a price of $0 per share under the 2022 Bankwell Financial Group, Inc. Stock Plan.
The restricted stock vests in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029. The Form 4 also lists Dale’s other holdings, including directly held common stock and 41,296 shares held indirectly through a Deferred Compensation Plan, along with prior restricted stock grants with multi‑year vesting schedules.
Bankwell Financial Group director Darryl Demos received a grant of 1,455 shares of restricted common stock on February 9, 2026. The award was granted at a price of $0 per share under the 2022 Stock Plan and is scheduled to vest in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029.
The Form 4 also shows Demos’ previously granted restricted stock awards, including 1,600 shares granted on December 30, 2022, 1,600 shares granted on December 29, 2023, and 1,800 shares granted on February 7, 2025, with portions of each already vested according to their multi-year schedules.
Bankwell Financial Group director Blake S. Drexler received a grant of 1,455 shares of restricted common stock on February 9, 2026 at $0 per share. These shares were issued under the 2022 Stock Plan and are scheduled to vest in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029.
In addition to this new award, he reports various existing direct and indirect holdings, including shares in an IRA/401(k), a deferred compensation plan, and 58,224 shares held by family members over which he exercises effective control. He also reports 160,861 directly held common shares.
Bankwell Financial Group director Jeffrey R. Dunne received an equity grant of 1,455 shares of common stock on February 9, 2026. The shares are restricted stock issued under the 2022 Bankwell Financial Group, Inc. Stock Plan at a stated price of $0 per share.
The grant vests in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029, aligning compensation with longer-term service. Following the transaction, he directly holds 1,455 restricted shares, along with other direct and indirect common stock holdings reported in the filing.
Bankwell Financial Group director Anahaita N. Kotval received a new equity award. On February 9, 2026, she was granted 1,455 shares of Bankwell common stock as restricted stock under the 2022 Stock Plan at a price of $0 per share.
The grant vests in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029. The filing also notes prior restricted stock grants from December 29, 2023 and February 7, 2025, and that 2,500 of her 6,666 directly held shares are owned jointly with her spouse.
Bankwell Financial Group director granted restricted stock
Bankwell Financial Group director Kevin D. Leitao received a grant of 1,455 shares of common stock on February 9, 2026 under the company’s 2022 stock plan. The award vests in three equal installments of 485 shares on February 7, 2027, 2028, and 2029.
A prior restricted stock grant of 1,800 shares from February 7, 2025 is also outstanding, with 600 shares vested on February 7, 2026 and another 600 shares scheduled to vest on February 7, 2027 and 2028, respectively.
Bankwell Financial Group director Carl M. Porto reported an equity award of common stock. On February 9, 2026, he received 1,455 shares of restricted stock at $0 per share under the 2022 Stock Plan. These shares are scheduled to vest in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029.
After this grant, Porto directly holds several blocks of common stock, including 1,455 newly granted restricted shares and other vested holdings, as well as indirect holdings through a law firm pension plan and a deferred compensation plan. No derivative securities are reported.
Bankwell Financial Group director Lawrence B. Seidman received a new equity grant in the company. On February 9, 2026, he was awarded 1,455 shares of Bankwell common stock as restricted stock at a price of $0 under the 2022 Stock Plan.
The grant vests in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029, aligning his compensation with longer-term performance. The filing also lists his existing direct holdings and substantial indirect ownership through several investment entities and plans.
Bankwell Financial Group, Inc. reported an equity grant to Chief Innovation Officer Ryan Jason Hildebrand. On February 9, 2026, he was awarded 3,116 shares of common stock at $0 under the 2022 Stock Plan.
Of this grant, 1,558 shares are time-based restricted stock vesting in three equal annual installments starting on February 7, 2027. The remaining 1,558 shares are performance restricted stock that vest on February 7, 2029 if the performance goal is achieved. Following the reported transaction, he directly beneficially owns 3,116 shares from this grant, 3,334 other common shares, and 15,000 performance restricted shares from earlier awards, all under the same 2022 Stock Plan.
Bankwell Financial Group EVP & CFO Courtney E. Sacchetti reported equity compensation and a related share sale in common stock of Bankwell Financial Group, Inc.
On February 9, 2026, Sacchetti received 1,994 common shares at $0 under the 2022 Stock Plan. According to the footnotes, 997 of these are time-based restricted stock vesting in three annual installments starting February 7, 2027, and 997 are performance restricted stock with a three-year cliff vesting on February 7, 2029 if performance goals are achieved.
Also on February 9, 2026, Sacchetti was granted and vested an additional 245 shares tied to 2024 and 2025 performance. To cover tax liabilities for vesting a total of 2,220 shares, 1,062 shares were withheld and sold through a company-sponsored cashless stock exercise program at a reported price of $49.79 per share, within a range of $49.47–$50.21. Following these transactions, Sacchetti reported direct ownership positions across several restricted and performance-based stock grants with varying vesting schedules.